Avermectin B1a

CAT:
804-HY-15308-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Avermectin B1a - image 1

Avermectin B1a

  • Description:

    Avermectin B1a is an antiparasitic agent that paralyzes nematodes without causing hypercontraction or flaccid paralysis.
  • Product Name Alternative:

    Abamectin B1a
  • UNSPSC:

    12352005
  • Hazard Statement:

    H300+H330, H372, H410
  • Target:

    Antibiotic; Parasite
  • Type:

    Reference compound
  • Related Pathways:

    Anti-infection
  • Field of Research:

    Infection
  • Assay Protocol:

    https://www.medchemexpress.com/Avermectin-B1a.html
  • Purity:

    98.26
  • Solubility:

    DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
  • Smiles:

    C[C@@H](CC)[C@]1([H])[C@@H](C)C=C[C@@]2(O[C@@]3([H])C[C@]([H])(OC([C@@]4([H])[C@@](/C(CO5)=C/C=C/[C@H](C)[C@H](O[C@@]6([H])C[C@H](OC)[C@@H](O[C@]7([H])O[C@@H](C)[C@H](O)[C@@H](OC)C7)[C@H](C)O6)/C(C)=C/C3)(O)[C@@]5([H])[C@H](O)C(C)=C4)=O)C2)O1
  • Molecular Formula:

    C48H72O14
  • Molecular Weight:

    873.08
  • Precautions:

    H300+H330, H372, H410
  • References & Citations:

    [1]Sun Y, et al. [Effects of avermectin B1a on soil microorganism and earthworm (Eisenia fetida) ]. Ying Yong Sheng Tai Xue Bao. 2005 Nov;16 (11) :2140-3.|[2]Sun Y, et al. Bioaccumulation and elimination of avermectin B1a in the earthworms (Eisenia fetida) . Chemosphere. 2005 Jul;60 (5) :699-704|[3]Huang J, et al. Avermectin B1a binds to high- and low-affinity sites with dual effects on the gamma-aminobutyric acid-gated chloride channel of cultured cerebellar granule neurons. J Pharmacol Exp Ther. 1997 Apr;281 (1) :261-6.|[4]Payne GT, et al. Activation of gamma-aminobutyric acid insensitive chloride channels in mouse brain synaptic vesicles by avermectin B1a. J Biochem Toxicol. 1991 Winter;6 (4) :283-92.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    No Development Reported
  • CAS Number:

    [65195-55-3]